Skip to main content

Clinical calculator could spare breast cancer patients five years of unnecessary hormone therapy

New research by Queen Mary University of London and The Royal Marsden NHS Foundation Trust confirms that an algorithm, called CTS5, accurately identifies patients who are at low risk of their breast cancer returning at a later stage.

Published on:
Back to top